 |
|
Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review
Lei Miao, Jing Xu, Giovanni Targher, Christopher D Byrne, Ming-Hua Zheng
Clin Mol Hepatol. 2022;28(4):725-738. Published online 2022 Mar 14 DOI: https://doi.org/10.3350/cmh.2022.0015
|
|
Citations to this article as recorded by
 Portal hypertension in nonalcoholic fatty liver disease: Challenges and perspectives
Lei Miao, Giovanni Targher, Christopher D. Byrne, Luca Valenti, Xiaolong Qi, MingâHua Zheng
Portal Hypertension & Cirrhosis.2022; 1(1): 57. CrossRef
|